🔗 Permalink

Inventor profile of:

Shankar Kumar

City:

Pleasanton, California

Country:

United States

Published Applications:

Last publication date:

2023-09-14

Top Assignees for applications by Shankar Kumar

The entities that hold a legal rights for patent applications filed by inventor Kumar Shankar:

Board of Regents, The University of Texas System 7 Austin, TX United States
ABBVIE INC. 6 North Chicago, IL United States
Gene Techno Science Co., Ltd. 3 Hokkaido, Japan
Abbott Laboratories 3 Abbott Park, IL United States
Pinteon Therapeutics Inc. 2 Newton Centre, MA United States
Kaken Pharmaceutical Co. 2 Tokyo, Japan
NATIONAL CHENG KUNG UNIVERSITY 2 Tainan, Taiwan
CHIOME BIOSCIENCE INC. 2 Tokyo, Japan
PDL BIOPHARMA, INC. 2 Fremont, CA United States
National Cheng Kung University 2 Tainan City, Taiwan
Progenics Pharmaceuticals, Inc. 1 Tarrytown, NY United States
LivTech Inc. — Teikyo University Biotechnology Research Center 1 Nogawa, Miyamae, Kawasaki, Kanagawa, Japan
Arius Research Inc. 1 Toronto, Ontario, Canada
LIVTECH, INC. 1 Kanagawa, Japan
LivTech Inc. 1 Tokyo, Japan
JN Biosciences LLC 1 Mountain View, CA United States

Recent patent applications by Kumar Shankar

Shankar Kumar from Pleasanton, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-09-14

US20230287093A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR THE GENERATION AND USE OF HUMANIZED CONFORMATION-SPECIFIC PHOSPHORYLATED TAU ANTIBODIES

#2 | 2020-11-19

US20200362022A1

Chemistry; metallurgy

Methods and compositions for the generation and use of humanized conformation-specific phosphorylated tau antibodies

#3 | 2019-04-04

US20190100596A1

Chemistry; metallurgy

Anti-OX40 antibodies and methods of using the same

#4 | 2019-01-10

US20190008966A1

Human necessities

Interleukin-13 binding proteins

#5 | 2017-11-30

US20170340737A1

Human necessities

Interleukin-13 binding proteins

#6 | 2017-09-21

US20170267773A1

Chemistry; metallurgy

Anti-OX40 antibodies and methods of using the same

#7 | 2016-11-17

US20160333110A1

Chemistry; metallurgy

Anti-human TROP-2 antibody having an antitumor activity in vivo

#8 | 2016-03-10

US20160068604A1

Chemistry; metallurgy

Nucleic acid encoding anti-OX40 antibodies

#9 | 2015-11-05

US20150315281A1

Chemistry; metallurgy

Anti-OX40 antibodies and methods of using the same

#10 | 2015-06-25

US20150175681A1

Chemistry; metallurgy

ANTIBODIES FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE-ASSOCIATED INFECTION AND DISEASE

#11 | 2015-04-30

US20150118711A1

Chemistry; metallurgy

Humanized anti-IL-20 antibody and uses thereof

#12 | 2015-01-01

US20150004178A1

Chemistry; metallurgy

ANTI-HUMAN SEMA4A ANTIBODIES USEFUL TO TREAT DISEASE

#13 | 2014-10-16

US20140308276A1

Chemistry; metallurgy

Anti-OX40 antibodies and methods of treating cancer

#14 | 2014-07-10

US20140193432A1

Chemistry; metallurgy

Anti-hDlk-1 antibody having an antitumor activity in vivo

#15 | 2014-06-26

US20140178332A1

Chemistry; metallurgy

IL-12/p40 BINDING PROTEINS

#16 | 2014-04-10

US20140099313A1

Chemistry; metallurgy

Interleukin-13 binding proteins

#17 | 2013-12-26

US20130344509A1

Chemistry; metallurgy

Anti-human TROP-2 antibody having an antitumor activity in vivo

#18 | 2013-11-28

US20130315893A1

Chemistry; metallurgy

Humanized anti-IL-20 antibody and uses thereof

#19 | 2013-10-24

US20130280275A1

Chemistry; metallurgy

Anti-OX40 antibodies and methods of using the same

#20 | 2013-08-08

US20130202618A1

Chemistry; metallurgy

Antibodies for the treatment of -associated infection and disease

#21 | 2011-12-08

US20110300139A1

Chemistry; metallurgy

Generation, expression and characterization of the humanized K33N monoclonal antibody

#22 | 2011-10-13

US20110250213A1

Chemistry; metallurgy

Antibodies to CD122

#23 | 2011-07-07

US20110165066A1

Human necessities

Interleukin-13 binding proteins

#24 | 2011-04-21

US20110091386A1

Chemistry; metallurgy

Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereof

#25 | 2010-12-30

US20100329980A1

Chemistry; metallurgy

Humanized anti-α 9 integrin antibodies and the uses thereof

#26 | 2010-08-05

US20100196315A1

Chemistry; metallurgy

IL-12/p40 binding proteins

#27 | 2010-02-25

US20100047245A1

Chemistry; metallurgy

IL-12/p40 binding proteins

#28 | 2009-12-03

US20090299038A1

Chemistry; metallurgy

Anti-hDlk-1 antibody having an antitumor activity in vivo

#29 | 2009-06-18

US20090155262A1

Physics

Cytotoxicity mediation of cells evidencing surface expression of CD63

#30 | 2008-09-18

US20080226632A1

Physics

AMPHIREGULIN ANTIBODIES AND THEIR USE TO TREAT CANCER AND PSORIASIS

#31 | 2008-07-17

US20080171014A1

Human necessities

Interleukin-13 binding proteins

#32 | 2007-05-29

US10774076

Amphiregulin antibodies and their use to treat cancer and psoriasis

#33 | 2007-02-01

US20070025912A1

Physics

Cytotoxicity mediation of cells evidencing surface expression of CD63

InventorID:

376389 ⎘